Is there a suitable method of anticoagulation in pregnant patients with mechanical prosthetic heart valves?

Interactive Cardiovascular and Thoracic Surgery

Volumn 15, Issue 3, 2012, Pages 484-488

  Malik, Humza T ^a   Sepehripour, Amir H ^b   Shipolini, Alex R ^a   McCormack, David J ^a  

^a LONDON CHEST HOSPITAL   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Anticoagulation; Bleeding; Heparin; Pregnancy; Prosthetic heart valve; Thromboembolism; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING DISORDER; CONGENITAL MALFORMATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; EMBRYOPATHY; EVIDENCE BASED MEDICINE; FETUS MALFORMATION; FETUS MORTALITY; FIRST TRIMESTER PREGNANCY; HEART VALVE PROSTHESIS; HUMAN; LOW DRUG DOSE; MATERNAL DISEASE; MATERNAL MORTALITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROSTHETIC VALVE THROMBOSIS; RISK ASSESSMENT; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; TERATOGENICITY; THROMBOEMBOLISM; THROMBOSIS; TREATMENT DURATION;

ANTICOAGULANTS; FEMALE; HEART VALVE PROSTHESIS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY TRIMESTER, FIRST; THROMBOEMBOLISM; YOUNG ADULT;

EID: 84869385341     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs178     Document Type: Article

References (10)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact CardioVasc Thorac Surg 2003;2:405-9. (Pubitemid 38112771)
2. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000;160:191-6. (Pubitemid 30054338)
3. McLintock C, McCowan LM, North RA. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valve treated with enoxaparin. BJOG 2009;116:1585-92.
4. Khamooshi AJ, Kashfi F, Hoseini S, Tabatabaei MB, Javadpour H, Noohi F. Anticoagulation for prosthetic heart valves in pregnancy. Is there an answer? Asian Cardiovasc Thorac Ann 2007;15:493-6.
5. Geelani MA, Singh S, Verma A, Nagesh A, Betigeri V, Nigam M. Anticoagulation in patients with mechanical valves during pregnancy. Asian Cardiovasc Thorac Ann 2005;13:30-3. (Pubitemid 40613202)
6. Meschengieser SS, Fondevila CG, Santarelli MT, Lazzari MA. Anticoagulation in pregnant women with mechanical heart valve prostheses. Heart 1999;82: 23-6. (Pubitemid 29309230)
7. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J 1994;71:196-201. (Pubitemid 24092707)
8. James AH, Brancazio LR, Gehrig TR, Wang A, Ortel TL. Lowmolecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves. J Matern Fetal Neonatal Med 2006;19: 543-9. (Pubitemid 44373606)
9. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637-41.
10. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2006;48:e1-148.